Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity ALLO - Allogene Therapeutics, Inc.
643 M
LAST VALUE
-21.33%
2 YEAR CAGR
-3.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR